TY - JOUR
T1 - Partners in Leaky Gut Syndrome
T2 - Intestinal Dysbiosis and Autoimmunity
AU - Kinashi, Yusuke
AU - Hase, Koji
N1 - Funding Information:
This study was supported by grants from the Japan Society for the Promotion of Science (20H00509, 20H05876, and JPJSBP 120207405 to KH), AMED-Crest (20gm1010004h0105 and 20gm1310009h0001 and to KH), and The Naito Foundation (KH).
Publisher Copyright:
© Copyright © 2021 Kinashi and Hase.
PY - 2021/4/22
Y1 - 2021/4/22
N2 - The intestinal surface is constitutively exposed to diverse antigens, such as food antigens, food-borne pathogens, and commensal microbes. Intestinal epithelial cells have developed unique barrier functions that prevent the translocation of potentially hostile antigens into the body. Disruption of the epithelial barrier increases intestinal permeability, resulting in leaky gut syndrome (LGS). Clinical reports have suggested that LGS contributes to autoimmune diseases such as type 1 diabetes, multiple sclerosis, rheumatoid arthritis, and celiac disease. Furthermore, the gut commensal microbiota plays a critical role in regulating host immunity; abnormalities of the microbial community, known as dysbiosis, are observed in patients with autoimmune diseases. However, the pathological links among intestinal dysbiosis, LGS, and autoimmune diseases have not been fully elucidated. This review discusses the current understanding of how commensal microbiota contributes to the pathogenesis of autoimmune diseases by modifying the epithelial barrier.
AB - The intestinal surface is constitutively exposed to diverse antigens, such as food antigens, food-borne pathogens, and commensal microbes. Intestinal epithelial cells have developed unique barrier functions that prevent the translocation of potentially hostile antigens into the body. Disruption of the epithelial barrier increases intestinal permeability, resulting in leaky gut syndrome (LGS). Clinical reports have suggested that LGS contributes to autoimmune diseases such as type 1 diabetes, multiple sclerosis, rheumatoid arthritis, and celiac disease. Furthermore, the gut commensal microbiota plays a critical role in regulating host immunity; abnormalities of the microbial community, known as dysbiosis, are observed in patients with autoimmune diseases. However, the pathological links among intestinal dysbiosis, LGS, and autoimmune diseases have not been fully elucidated. This review discusses the current understanding of how commensal microbiota contributes to the pathogenesis of autoimmune diseases by modifying the epithelial barrier.
KW - autoimmune diseases
KW - dysbiosis
KW - epithelial barrier
KW - gut immune system
KW - leaky gut syndrome
KW - microbiota
UR - http://www.scopus.com/inward/record.url?scp=85105406352&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85105406352&partnerID=8YFLogxK
U2 - 10.3389/fimmu.2021.673708
DO - 10.3389/fimmu.2021.673708
M3 - Review article
C2 - 33968085
AN - SCOPUS:85105406352
SN - 1664-3224
VL - 12
JO - Frontiers in Immunology
JF - Frontiers in Immunology
M1 - 673708
ER -